Weight Loss

Page 5 of 6

How Richard Simmons, a former overweight teen, became a celebrity weight loss coach and workout icon
Health

How Richard Simmons, a former overweight teen, became a celebrity weight loss coach and workout icon

By Mark Kennedy and The Associated Press
July 14, 2024
A bathroom scale is surrounded by colorful pills.
Health

Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots

By Damian Garde and Bloomberg
July 11, 2024
A person using Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that manufactures Ozempic, has reported record quarterly results, up almost 3% on the stock market. The company's revenues rose by 38% to DKK 58.73 billion, some 7.8 billion euros. Ozempic is a diabetic drug that causes a loss of up to 15% of body weight because it acts as an appetite suppressant, a side effect that has made the drug fashionable on social media as a weight loss drug.
Features

Ozempic and Wegovy are marketed as a short-term holy grail for weight loss by some startups. Doctors disagree

By Jessica Mathews and Alena Botros
July 9, 2024
Close-up of an Ozempic pen in a greenwash style
Health

Ozempic linked to rare cases of vision loss in Harvard study

By Robert Langreth and Bloomberg
July 3, 2024
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
Health

Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs

By
June 28, 2024
EU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics
Health

EU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics

By Naomi Kresge and Bloomberg
June 26, 2024
Lars Fruergaard Jorgensen, CEO of Novo Nordisk.
Health

Novo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project

By Naomi Kresge and Bloomberg
June 25, 2024
Baggy pants are out and smaller sizes are flying off the shelves as Wegovy changes how Americans buy clothes
Retail

Baggy pants are out and smaller sizes are flying off the shelves as Wegovy changes how Americans buy clothes

By
June 17, 2024
Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk A/S, gestures while speaking during a Bloomberg Television interview in London, U.K.
Retail

Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why

By
June 17, 2024
Ozempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the viral drugs are in stock
Health

Ozempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the viral drugs are in stock

By
May 29, 2024
Dr. Razia Hashmi, vice president of clinical affairs, Blue Cross Blue Shield Association, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., on Tuesday, May 21, 2024.
Health

GLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study

By
May 22, 2024
Dr. Patrick Carroll (right), Hims & Hers chief medical officer, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., Monday, May 20, 2024.
Conferences

Hims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says

By
May 21, 2024
People living with obesity reap the greatest health benefits from being physically active in the evening, according to a new Australian study.
Life

This is the best time of day to exercise for people living with obesity, new study shows

By
May 18, 2024
Employees are secretly bringing their own AI tools to work so they can keep up
Newsletters

Employees are secretly bringing their own AI tools to work so they can keep up

By
May 10, 2024
Insulin injection pen
Newsletters

How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs

By
May 3, 2024

Most Popular